Comparative review of novel model-assisted designs for phase I/II clinical trials

DOI10.1002/BIMJ.202300398zbMATH Open1547.62457MaRDI QIDQ6625482

Ruitao Lin, Haolun Shi, Xiaolei Lin

Publication date: 28 October 2024

Published in: Biometrical Journal (Search for Journal in Brave)

zbMATH Keywords

operating characteristicsdose findingclinical trial designmodel-assisted designphase I/II trials

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
• Dose-Finding Based on Efficacy-Toxicity Trade-Offs
• Design and Analysis of Phase I Clinical Trials
• Semiparametric Dose Finding Methods
• The Isotonic Regression Problem and Its Dual
• uTPI: a utility-based toxicity probability interval design for phase I/II dose-finding trials

This page was built for publication: Comparative review of novel model-assisted designs for phase I/II clinical trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6625482)